 The Medical Device Authority of Malaysia has approved Altamira Therapeutics Ltds NASDAQ: CYTO Bentrio. We are very pleased with the swift go-to-market progress in Malaysia and Singapore, commented Thomas Meyer, Founder, Chairman, and CEO. 